CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $505,000 | +7.4% | 62,187 | 0.0% | 0.03% | +6.5% |
Q2 2021 | $470,000 | -13.0% | 62,187 | 0.0% | 0.03% | -20.5% |
Q1 2021 | $540,000 | +8.9% | 62,187 | 0.0% | 0.04% | -11.4% |
Q4 2020 | $496,000 | 0.0% | 62,187 | 0.0% | 0.04% | -18.5% |
Q3 2020 | $496,000 | -19.5% | 62,187 | 0.0% | 0.05% | -29.9% |
Q2 2020 | $616,000 | +28.1% | 62,187 | 0.0% | 0.08% | +8.5% |
Q1 2020 | $481,000 | +100.4% | 62,187 | -0.1% | 0.07% | +129.0% |
Q4 2019 | $240,000 | -23.3% | 62,279 | 0.0% | 0.03% | -31.1% |
Q3 2019 | $313,000 | -23.7% | 62,279 | +0.3% | 0.04% | -30.8% |
Q2 2019 | $410,000 | -12.8% | 62,079 | 0.0% | 0.06% | -18.8% |
Q1 2019 | $470,000 | -6.4% | 62,079 | 0.0% | 0.08% | -17.5% |
Q4 2018 | $502,000 | -37.3% | 62,079 | 0.0% | 0.10% | -34.0% |
Q3 2018 | $801,000 | +13.1% | 62,079 | 0.0% | 0.15% | +5.8% |
Q2 2018 | $708,000 | +61.6% | 62,079 | 0.0% | 0.14% | +40.4% |
Q1 2018 | $438,000 | +14.4% | 62,079 | +5.4% | 0.10% | +1.0% |
Q4 2017 | $383,000 | +4.9% | 58,899 | 0.0% | 0.10% | -9.3% |
Q3 2017 | $365,000 | – | 58,899 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 450,000 | $846,000 | 0.90% |
Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |